Table 3.
CMAP (<3 mV), (n = 129) | CMAP (3–4 mV), (n = 206) | CMAP (>4 mV), (n = 906) | Beta+ SE | Pa | |
---|---|---|---|---|---|
Saturated fatty acids (%) | 32.4 ± 3.0 | 32.4 ± 3.0 | 32.4 ± 2.8 | 0.041 ± 0.036 | 0.25 |
Monounsaturated fatty acids (%) | 31.9 ± 3.5 | 31.1 ± 3.4 | 30.2 ± 3.8 | −0.045 ± 0.28 | 0.10 |
Polyunsaturated fatty acids (%) | 35.8 ± 4.8 | 36.5 ± 4.7 | 37.3 ± 5.0 | 0.012 ± 0.021 | 0.58 |
Omega-6 fatty acids (mg/l) | 1020.0 ± 251.9 | 1040.4 ± 236.2 | 1065.0 ± 234.6 | 0.0007 ± 0.0004 | 0.09 |
Linoleic acid (mg/l) | 765.2 ± 196.1 | 769.1 ± 172.8 | 803.6 ± 179.4 | 0.001 ± 0.0005 | 0.06 |
Arachidonic acid (mg/l) | 251.2 ± 78.1 | 267.6 ± 86.4 | 269.9 ± 81.1 | 0.0009 ± 0.001 | 0.46 |
Omega-3 fatty acids (mg/l) | 107.0 ± 42.8 | 107.3 ± 38.8 | 109.2 ± 41.2 | 0.266 ± 0.254 | 0.30 |
Linolenic acid (mg/l) | 14.9 ± 9.7 | 14.5 ± 10.4 | 14.8 ± 9.3 | 0.006 ± 0.01 | 0.56 |
Eicosapentaenoic acid (mg/l) | 19.7 ± 9.1 | 19.5 ± 7.4 | 19.9 ± 8.6 | 0.014 ± 0.011 | 0.21 |
Docosahexaenoic acid (mg/l) | 72.4 ± 31.1 | 73.3 ± 28.5 | 74.5 ± 30.5 | 0.0016 ± 0.003 | 0.62 |
Ratio n-6/n-3 | 10.5 ± 3.3 | 10.6 ± 3.6 | 10.6 ± 3.0 | 0.01 ± 0.03 | 0.64 |
Values are given as mean ± SD.
General linear model with CMAP considered as a continuous variable and adjusted for age, sex, body mass index, total cholesterol, triglycerides, diabetes and peripheral artery disease.